Ischemia-modified albumin in migraine patients during interictal period

Ischemia-modified albumin in migraine patients during interictal period

Aim. Ischemia-modified albumin (IMA) is a marker of myocardial ischemia and may be affected by ischemia occurring in other tissues. Migraine has been reported as a risk factor of ischemic stroke or cardiovascular events. Dysfunction of endothelial cells, as well as association with arteriopathies wa...

Full description

Bibliographic Details
Main Authors: Slawomir Michalak, Krystyna Osztynowicz, Alicja Płóciniczak, Waldemar Myszka, Marcin Nowicki, Danuta Węgrzyn, Małgorzata Drzewiecka, Kinga Kapecka, Wojciech Kozubski
Format: Article
Language:English
Published: Poznan University of Medical Sciences 2016-12-01
Series:Journal of Medical Science
Subjects:
headache
ischemia-modified albumin
oxidative stress
cerebrovascular diseases
Online Access:https://jms.ump.edu.pl/index.php/JMS/article/view/170

Internet

https://jms.ump.edu.pl/index.php/JMS/article/view/170

Similar Items